Abstract
When people think of medicine, they often picture stethoscopes, routine clinical checkups, surgeries, and standard prescriptions. One field that needs more acknowledgement is the technological side. As technology continues to evolve, healthcare advances alongside it, with nanotechnology emerging as a substantial area of innovation. This paper reflects the expanding role of nanotechnology in modern medicine, focusing on its potential applications in trauma and internal medicine care and in the treatment of blood and bone disorders as well as bone and blood related cancers. By working at an extremely small scale, nanotechnology allows for more precise and targeted treatment, reducing damage to healthy tissues. Current research presents the development of artificial red blood cells for improved oxygen delivery during trauma situations, as well as nanoparticle-based carriers designed to treat hematological conditions such as hemophilia. Nanotechnology also shows potential in strengthening bone structure and supporting regeneration in osteological disorders like osteoporosis. Despite challenges related to safety, cost, and long-term clinical testing, ongoing research shows that nanotechnology could significantly improve emergency response and long-term treatment outcomes. Overall, nanotechnology is going to be established as a future tool in managing chronic blood and bone diseases.
Year Manuscript Completed
Spring 2026
Senior Project Advisor
George Barton
Degree Awarded
Bachelor of Integrated Studies Degree
Field of Study
Health & Exercise Studies
Document Type
Thesis
Recommended Citation
Hamilton, Chase K., "Advancing Nanotechnology for Hematological and Osteological Disorders" (2026). Integrated Studies. 691.
https://digitalcommons.murraystate.edu/bis437/691